general malaise 6 hours; First 4 doses upon injection shooting pain down arm to wrist; First 4 doses upon injection shooting pain down arm to wrist; pain in arm 4-5 hours; pounding headache 3-4 hours; intermittent visual focus disturbances 5-6 hours; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 70-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 11Mar2021 at 11:45 as dose 1, single (Lot number: EN6208) at the age of 70 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Other Medical History: Uticaria from eye drops & neomycin" (unspecified if ongoing), notes: Other Medical History: Uticaria from eye drops & neomycin; "Other Medical History: digestive issues (food allergies)" (unspecified if ongoing), notes: Other Medical History: digestive issues (food allergies); "Other Medical History: sinusitis" (unspecified if ongoing), notes: Other Medical History: sinusitis (food allergies); "Other Medical History: eustacian tube inflammation" (unspecified if ongoing), notes: Other Medical History: eustacian tube inflammation; "Known allergies: penicillin" (unspecified if ongoing), notes: Known allergies: penicillin; "Known allergies: sulfa" (unspecified if ongoing), notes: Known allergies: sulfa; "Known allergies: other antibiotics topical" (unspecified if ongoing), notes: Known allergies: other antibiotics topical; "Known allergies: additives in eye drops" (unspecified if ongoing), notes: Known allergies: additives in eye drops; "food allergies" (unspecified if ongoing), notes: digestive issues (food allergies),/ sinusitis, (food allergies),. Concomitant medication(s) included: ARMOUR THYROID. Past drug history included: Known allergies: neomycin, reaction(s): "Drug allergy", notes: Known allergies: neomycin; Neomycin, reaction(s): "other medical history:Uticaria from neomycin", notes: other medical history: Uticaria from eye drops & neomycin,. The following information was reported: VACCINATION SITE PAIN (non-serious), ARTHRALGIA (non-serious) all with onset 11Mar2021 at 11:00, outcome "recovered" and all described as "First 4 doses upon injection shooting pain down arm to wrist"; MALAISE (non-serious) with onset 11Mar2021 at 11:00, outcome "recovered", described as "general malaise 6 hours"; VISUAL IMPAIRMENT (non-serious) with onset 11Mar2021 at 11:00, outcome "recovered", described as "intermittent visual focus disturbances 5-6 hours"; PAIN IN EXTREMITY (non-serious) with onset 11Mar2021 at 11:00, outcome "recovered", described as "pain in arm 4-5 hours"; HEADACHE (non-serious) with onset 11Mar2021 at 11:00, outcome "recovered", described as "pounding headache 3-4 hours". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of malaise, vaccination site pain, arthralgia, pain in extremity, headache, visual impairment.  Additional information: If other vaccine in four weeks: No. Other medications in two weeks: Armour thyroid 75mcg. First 4 doses upon injection shooting pain down arm to wrist, continued pain in arm 4-5 hours, pounding headache 3-4 hours, intermittent visual focus disturbances 5-6 hours, general malaise 6 hours. if covid prior vaccination: No. if covid tested post vaccination: Yes. Covid test post vaccination: Covid test type post vaccination: Nasal swab, Covid test name post vaccination: PCR, Covid test date: 27Jun2021, Covid test result: Negative.  No follow-up attempts are possible. No further information is expected.